|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Future developments in hormonal contraception. |
| American Journal of Obstetrics and Gynecology. 2004 Apr;190(4 Suppl 1):S69-S71. |
| The range of contraception options has recently increased to include long-term, reversible, and highly effective |
| methods. Several new oral contraceptive (OC) formulations are now available in the United States, where OCs are the |
| most popular reversible method. Long-term contraceptive systems that deliver hormones via subdermal implants, |
| vaginal ring, intrauterine system, and transdermal patch afford convenient and effective alternatives to OCs. |
| Contraceptives using hormone combinations appear to be especially effective with safety profiles comparable to |
| OCs. All recently approved in the United States, the transdermal contraceptive patch offers once-weekly dosing with |
| an improved compliance profile, the monthly vaginal ring has the convenient advantage of being user-controlled; a |
| monthly combination injectable provides good pregnancy protection and improved bleeding control compared with |
| the progestin-only formulatin; and the 5-year the levonorgestrel-releasing intrauterine system significantly diminishes |
| menstrual blood loss. A single subdermal implant has been approved for use in Europe. With 60% of all unintended |
| pregnancies occurring in women using birth control, it is anticipated that this increasing range of options will |
| enhance compliance and provide more effective contraception suitable for the individual user. (PubHealth.info |
| Document ID: CONT1T 564-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Future developments in hormonal contraception.", is(are) |
| Johansson ED. The source of this article is "American Journal of Obstetrics and Gynecology. 2004 Apr;190(4 Suppl |
| 1):S69-S71.". This article was published in 2004 in English language(s). (PubHealth.info® Document ID: CONT1T |
| 564-06. All rights reserved with PubHealth.info) PIN: 564 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |